Functional expression and characterization of CYP51 from dandruff-causing Malassezia globosa

FEMS Yeast Research

Volumn 11, Issue 1, 2011, Pages 80-87

  Kim, Donghak ^a   Lim, Young Ran ^a   Ohk, Seul Ong ^b   Kim, Beom Joon ^b   Chun, Young Jin ^b  

^a Konkuk University   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Azole; CYP51; Cytochrome P450; Expression; Malassezia globosa

Indexed keywords

CYTOCHROME P450; ECONAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; STEROL 14ALPHA DEMETHYLASE;

AMINO ACID SEQUENCE; ANTIFUNGAL ACTIVITY; ANTIFUNGAL RESISTANCE; ARTICLE; CASE REPORT; DANDRUFF; DRUG PROTEIN BINDING; ESCHERICHIA COLI; FUNGAL CELL CULTURE; FUNGAL STRAIN; FUNGUS ISOLATION; GENE MUTATION; HUMAN; IMMUNOBLOTTING; MALASSEZIA GLOBOSA; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIFUNGAL AGENTS; AZOLES; CLONING, MOLECULAR; DRUG RESISTANCE, FUNGAL; ESCHERICHIA COLI; FUNGAL PROTEINS; GENE EXPRESSION; HUMANS; KINETICS; MALASSEZIA; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROTEIN BINDING; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SPECTRUM ANALYSIS; STEROL 14-DEMETHYLASE; TINEA VERSICOLOR;

ESCHERICHIA COLI; MALASSEZIA GLOBOSA;

EID: 78651415147     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2010.00692.x     Document Type: Article

References (31)

1. Aoyama Y, Horiuchi T, Gotoh O, Noshiro M & Yoshida Y (1998) CYP51-like gene of Mycobacterium tuberculosis actually encodes a P450 similar to eukaryotic CYP51. J Biochem 124: 694-696.
2. Cafarchia C & Otranto D (2008) The pathogenesis of Malassezia yeasts. Parassitologia 50: 65-67.
3. Correia MA & Ortiz de Montellano PR (2005) Inhibition of cytochrome P450 enzymes. Cytochrome P450: Structure, Mechanism, and Biochemistry (Ortiz de Montellano PR, ed), pp. 247-322. Plenum Press, New York.
4. Faergemann J (1997) Pityrosporum yeasts - what's new? Mycoses 40 (suppl 1): 29-32.
5. Gemmer CM, DeAngelis YM, Theelen B, Boekhout T & Dawson TL Jr (2002) Fast, noninvasive method for molecular detection and differentiation of Malassezia yeast species on human skin and application of the method to dandruff microbiology. J Clin Microbiol 40: 3350-3357.
6. Guengerich FP (2002) Cytochrome P450 enzymes in the generation of commercial products. Nat Rev Drug Discov 1: 359-366.
7. Guengerich FP (2003) Cytochromes P450, drugs, and diseases. Mol Interv 3: 194-204.
8. Guillot J, Hadina S & Gueho E (2008) The genus Malassezia: old facts and new concepts. Parassitologia 50: 77-79.
9. Kelly SL, Kelly DE, Jackson CJ, Warrilow AGS & Lamb DC (2005) The diversity and importance of microbial cytochrome P450. Cytochrome P450: Structure, Mechanism, and Biochemistry (Ortiz de Montellano PR, ed), pp. 585-617. Plenum Press, New York.
10. Kim BJ, Lee EC, Lim YY, Kim D & Chun YJ (2009) Optimal culture condition for antifungal susceptibility tests of Malassezia globosa. Kor J Med Mycol 14: 182-189.
11. Kim D & Guengerich FP (2004) Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation. Biochemistry 43: 981-988.
12. Kim D, Wu ZL & Guengerich FP (2005) Analysis of coumarin 7-hydroxylation activity of cytochrome P450 2A6 using random mutagenesis. J Biol Chem 280: 40319-40327.
13. Kim D, Yukl ET, Moenne-Loccoz P & Ortiz de Montellano PR (2006) Fungal heme oxygenases: functional expression and characterization of Hmx1 from Saccharomyces cerevisiae and CaHmx1 from Candida albicans. Biochemistry 45: 14772-14780.
14. Koga H, Nanjoh Y, Makimura K & Tsuboi R (2009) In vitro antifungal activities of luliconazole, a new topical imidazole. Med Mycol 47: 640-647.
15. Koltin Y & Hitchcock CA (1997) The search for new triazole antifungal agents. Curr Opin Chem Biol 1: 176-182.
16. Kudo M, Ohi M, Aoyama Y, Nitahara Y, Chung SK & Yoshida Y (2005) Effects of Y132H and F145L substitutions on the activity, azole resistance and spectral properties of Candida albicans sterol 14-demethylase P450 (CYP51): a live example showing the selection of altered P450 through interaction with environmental compounds. J Biochem 137: 625-632.
17. Lepesheva GI, Virus C & Waterman MR (2003) Conservation in the CYP51 family. Role of the B' helix/BC loop and helices F and G in enzymatic function. Biochemistry 42: 9091-9101.
18. Lepesheva GI, Hargrove TY, Kleshchenko Y, Nes WD, Villalta F & Waterman MR (2008) CYP51: a major drug target in the cytochrome P450 superfamily. Lipids 43: 1117-1125.
19. Matsuura K, Yoshioka S, Tosha T et al. (2005) Structural diversities of active site in clinical azole-bound forms between sterol 14α-demethylases (CYP51s) from human and Mycobacterium tuberculosis. J Biol Chem 280: 9088-9096.
20. Miranda KC, de Araujo CR, Costa CR, Passos XS, de Fátima Lisboa Fernandes O & do Rosário Rodrigues Silva M (2007) Antifungal activities of azole agents against the Malassezia species. Int J Antimicrob Ag 29: 281-284.
21. Nelson DR, Koymans L, Kamataki T et al. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6: 1-42.
22. Notredame C, Higgins DG & Heringa J (2000) T-coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 302: 205-217.
23. Omura T & Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239: 2370-2378.
24. Ortiz de Montellano PR (2005) Cytochrome P450: Structure, Mechanism, and Biochemistry, 3rd edn. Plenum Press, New York.
25. Podust LM, Poulos TL & Waterman MR (2001) Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. P Natl Acad Sci USA 98: 3068-3073.
26. Riciputo RM, Oliveri S, Micali G & Sapuppo A (1996) Phospholipase activity in Malassezia furfur pathogenic strains. Mycoses 39: 233-235.
27. Schenkman JB, Remmer H & Estabrook RW (1967) Spectral studies of drug interaction with hepatic microsomal cytochrome P-450. Mol Pharmacol 3: 113-123.
28. Sheehan DJ, Hitchcock CA & Sibley CM (1999) Current and emerging azole antifungal agents. Clin Microbiol Rev 12: 40-79.
29. Strushkevich N, Usanov SA & Park HW (2010) Structural basis of human CYP51 inhibition by antifungal azoles. J Mol Biol 397: 1067-1078.
30. Xu J, Saunders CW, Hu P et al. (2007) Dandruff-associated Malassezia genomes reveal convergent and divergent virulence traits shared with plant and human fungal pathogens. P Natl Acad Sci USA 104: 18730-18735.
31. Zisova LG (2009) Malassezia species and seborrheic dermatitis. Folia Med 51: 23-33.